BSE Live
Sep 05, 16:01Prev. Close
1369.90
Open Price
1371.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Sep 05, 15:58Prev. Close
1370.70
Open Price
1369.10
Bid Price (Qty.)
1372.70 (26)
Offer Price (Qty.)
0.00 (0)
Profit & Loss account of Emcure Pharmaceuticals (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
INCOME | ||||||
Revenue From Operations [Gross] | 2,335.68 | 2,406.73 | 2,218.29 | 2,053.58 | 2,139.42 | |
Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 7.81 | 40.85 | 38.73 | |
Revenue From Operations [Net] | 2,335.68 | 2,406.73 | 2,210.48 | 2,012.73 | 2,100.69 | |
Total Operating Revenues | 2,375.71 | 2,453.70 | 2,241.43 | 2,057.79 | 2,137.01 | |
Other Income | 137.62 | 90.88 | 61.00 | 37.46 | 40.42 | |
Total Revenue | 2,513.32 | 2,544.58 | 2,302.43 | 2,095.25 | 2,177.43 | |
EXPENSES | ||||||
Cost Of Materials Consumed | 559.85 | 533.53 | 370.95 | 319.08 | 391.22 | |
Purchase Of Stock-In Trade | 191.61 | 196.55 | 177.36 | 262.68 | 308.75 | |
Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Changes In Inventories Of FG,WIP And Stock-In Trade | 59.70 | 14.71 | 60.34 | -49.03 | -91.92 | |
Employee Benefit Expenses | 545.35 | 516.14 | 484.13 | 465.73 | 418.99 | |
Finance Costs | 137.22 | 126.65 | 88.05 | 100.41 | 75.73 | |
Depreciation And Amortisation Expenses | 154.97 | 129.84 | 119.97 | 115.83 | 104.43 | |
Other Expenses | 595.78 | 622.36 | 621.04 | 558.31 | 518.47 | |
Total Expenses | 2,244.48 | 2,139.79 | 1,921.84 | 1,773.02 | 1,725.66 | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 268.84 | 404.79 | 380.58 | 322.23 | 451.77 | |
Exceptional Items | -44.16 | -34.96 | -38.14 | -98.37 | -54.39 | |
Profit/Loss Before Tax | 224.68 | 369.84 | 342.45 | 223.86 | 397.37 | |
Tax Expenses-Continued Operations | ||||||
Current Tax | 74.43 | 91.35 | 87.11 | 40.17 | 76.71 | |
Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax | -23.34 | -5.17 | 8.00 | -33.46 | 2.71 | |
Tax For Earlier Years | -1.62 | 0.00 | 4.57 | 0.00 | 0.00 | |
Total Tax Expenses | 49.48 | 86.18 | 99.68 | 6.70 | 79.41 | |
Profit/Loss After Tax And Before ExtraOrdinary Items | 175.21 | 283.65 | 242.77 | 217.16 | 317.96 | |
Profit/Loss From Continuing Operations | 175.21 | 283.65 | 242.77 | 217.16 | 317.96 | |
Profit/Loss For The Period | 175.21 | 283.65 | 242.77 | 217.16 | 317.96 | |
OTHER ADDITIONAL INFORMATION | ||||||
EARNINGS PER SHARE | ||||||
Basic EPS (Rs.) | 9.69 | 15.68 | 13.42 | 12.01 | 17.58 | |
Diluted EPS (Rs.) | 9.69 | 15.68 | 13.42 | 12.01 | 17.58 | |
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
Equity Share Dividend | 45.21 | 81.38 | 54.26 | 27.13 | 79.12 | |
Tax On Dividend | 3.06 | 15.25 | 10.23 | 3.90 | 12.86 | |
Equity Dividend Rate (%) | 25.00 | 35.00 | 35.00 | 15.00 | 100.00 |
07.08.2025
Emcure Pharmace Standalone June 2025 Net Sales at Rs 1,096.57 crore, up 13.01% Y-o-Y
17.07.2025
10.07.2025
07.07.2025
07.08.2025
Emcure Pharmace Standalone June 2025 Net Sales at Rs 1,096.57 crore, up 13.01% Y-o-Y
27.05.2025
Emcure Pharmace Consolidated March 2025 Net Sales at Rs 2,116.25 crore, up 19.47% Y-o-Y
23.05.2025
Emcure Pharmace Standalone March 2025 Net Sales at Rs 1,278.19 crore, up 41.62% Y-o-Y
12.02.2025
Emcure Pharmace Standalone December 2024 Net Sales at Rs 1,028.81 crore, up 18.23% Y-o-Y